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The hormonal changes that occur in a short time span 
promote modifications all over the woman’s body, with 
physical and emotional manifestations which are frequently 
observed. Aim: to evaluate the activity of the external ciliated 
cells in women during their menstrual cycle, observing the 
effect of hormonal changes caused by the cycle in their 3 
phases. Methods: this is a longitudinal prospective study 
where 21 women between 20 and 35 years old who did not 
take any contraceptive medicine were assessed. Transient 
otoacoustic emissions were evaluated by distortion product 
during the 3 phases of the menstrual cycle (luteal, follicular 
and ovulatory phases). The SPSS 13.0 software was used 
to analyze the data. Results: the phases of menstrual cycle 
do not alter the amplitude and reproducibility values of the 
transient otoacoustic emissions. We noticed a difference 
between the ears in the frequency of 1.5 KHz in the amplitude 
of emissions by distortion product, and the right ear showed 
the highest values. Conclusion: There are no significant 
differences in transient otoacoustic emissions and distortion 
products in the phases of the menstrual cycle.
Keywords: hormonal cycle, ciliated cells, otoacoustic 
emissions.
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INTRODUCTION
The menstrual cycle is divided into three phases. 
The follicular phase starts with menstrual bleeding and 
lasts, on average, 15 days. The ovulatory phase lasts about 
three days, culminating in ovulation, when an ovule is 
released. The luteal phase lasts about 13 days and ends 
with the beginning of menstruation, which begins a new 
cycle.
In the ovulatory phase, soon after ovulation, proges-
terone levels increase, and LH/FSH (luteinizing hormone/
follicle-stimulating hormone) and estrogen levels decrease. 
Progesterone levels peak in the luteal phase as LH/FSH 
levels decrease still further. High progesterone levels may 
increase sodium, chloride and water reabsorption. The 
cycle ends when progesterone and LH/FSH levels are at 
a minimum, after which a new cycle begins.1
Hormone level variations in a short timeframe alter 
the whole female organism, leading to physical and emo-
tional manifestations that may be quite evident. A previous 
study2 found a decrease in the fundamental frequency of 
voice in women during the premenstrual period. This pe-
riod is the end of the luteal phase, in which progesterone 
and LH/FSH levels drop significantly. Homeostasis and 
the biochemical status of inner ear fluid is essential for 
balance and for hearing.3 Changes in sodium and water 
reabsorption that take place during the menstrual cycle 
may affect the function of this part of the peripheral au-
ditory system, and may affect homeostatis, which causes 
auditory and labyrinthic symptoms.3
Various studies have tested the hypothesis that 
estrogen concentration variations in women change the 
functional cerebral asymmetry.4-6 Right-ear dominance 
in verbal auditory tasks indirectly reveals a left cerebral 
advantage for dealing with these stimuli. When testing is 
done across the menstrual cycle, the right ear advantage is 
observed to decrease in the premenstrual period compared 
to the postmenstrual period.6 
The cochlea, located in the inner ear, has an active 
mechanism that might be subdivided into three separate 
steps, as follows:
STEP 1: mechanoelectrical transduction of outer hair 
cells - the stirrup exerts pressure on the oval window, whi-
ch propagates the resulting vibrations into the perilymph, 
causing the basilar membrane and the organ of Corti to os-
cillate. These oscillations deflect outer hair cell stereocilia, 
which are coupled to the tectorial membrane. Stimulation 
is frequency-dependent, as the basilar membrane vibrates 
differently at high frequencies (the oscillation peak is close 
to the base of the cochlea) and at low frequencies (the 
oscillation peak is close to the apical turn of the cochlea). 
Deflections of the stereocilia open potassium channels on 
the cell membrane, generating receptor electrical potentials 
or cochlear microphonic potentials.7 
STEP 2: electromechanical transduction of outer hair 
cells - the potentials that are generated produce rapid con-
tractions of the outer hair cells in phase with the frequency 
of a sound stimulus. The rapid contraction mechanism is 
the basis of the cochlear active amplification process; the 
cells connect basilar and tectorial membrane vibrations 
(both vibrating in phase), resulting in amplification of the 
original source frequency.7 
STEP 3: mechanoelectrical transduction of inner hair 
cells - the actively outer hair cell amplified vibration from 
the basilar and tectorial membranes deflects the longer cilia 
(in contact with the tectorial membrane) of those inner hair 
cells located in the region corresponding to the stimulus 
frequency. This deflection causes potassium to enter the 
cell, generating a receptor potential that releases neuro-
transmitters, forming an electrical stimulus corresponding 
to the sound message.7 Information is then transmitted 
along the acoustic nerve to the central nervous system.
Analysis of otoacoustic emissions (OAE) is a test 
that reads, in the auditory canal, sounds generated by 
outer hairy cell contractions following the presentation of 
a sound stimulus. OAE may be spontaneous or evoked. 
Spontaneous OAE are found in about 40% of normal-hea-
ring subjects;8 evoked OAE are a release of energy picked 
up in the acoustic canal as a response to acoustic stimuli, 
which may be a click (transients) or two pure sounds 
(distortion products).9 This test provides information 
about outer hair cell integrity during the active cochlear 
mechanism.10 A hypothesis suggests that hormonal chan-
ges might be responsible for inner ear diseases, such as 
Ménière’s disease.8 There is a consensus in the literature 
that OAE reception is highly stable, which justifies its me-
dical use.11,12 The amplitude of OAE evoked by transient 
stimuli or distortion products in audiologically normal 
subjects may vary according to the frequency being tested, 
or between subjects. Amplitude within a given subject, 
however, is remarkably consistent.12 Changes due to noise, 
drugs, disease or efferent excitation taking place in minutes 
may be monitored.11  
Menstrual cycle variations in sodium and water 
absorption and reabsorption affect the active mechanism 
of the cochlea; the amplitude of OAE may be used to as-
sess such variations in each phase of the cycle.3 Previous 
studies of fluctuations in spontaneous OAE frequencies 
appear to follow the same pattern of estradiol concentra-
tion fluctuations during the cycle.13 In the normal menstrual 
cycle the frequency decreases before menstruation and 
increases immediately after a new cycle begins. Natural or 
medication-induced anovulation reduces the characteristic 
OAE fluctuations during the cycle.
The aim of this paper was to assess hair cell activity 
in women during the menstrual cycle, noting the effects 
of hormone variations in each of its three phases.
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MATERIAL AND METHOD
The Research Ethics Committee of the Health 
Sciences School, Brasilia University, approved this study 
(protocol number 082/2005).
 
Participants
Twenty-one women aged between 20 and 35 years 
(to exclude the effects of aging) not using contraceptive 
medication or hormones (to avoid data contamination) 
were included (information was obtained in clinical his-
tory-taking).
Participants were connected to the institution as 
teachers, staff or students, and were evaluated in three 
consultations with tests in the School Clinic.
 
Procedures
Participants were informed about the study and, 
upon agreement, signed a free informed consent form.
The 21 women were interviewed to collect the 
history, otological history, information about the use of 
medication and about their menstrual cycles. Basic au-
diological assessments were made (meatoscopy and pure 
tone audiometry).
Upon finding no auditory conditions, an assessment 
of TOAE and DPOAE was made. These procedures were 
conducted three times, as follows: during the follicular 
phase, during the ovulatory phase and during the luteal 
phase. The aim was to assess cochlear activity in all of the 
phases of the cycle.
 
Material
§ Audiological history of the adult (School Clinic) 
- adapted
§ Maico audiometer - models MA-41 and MA-42
§ ILO-92 Cochlear Analyzer coupled to a PC
§ Non-acoustically treated room (along a little used 
aisle)
 
Analysis of Responses
TOAE were considered as present when 1 and 1.5 
kHz frequency amplitudes were equal to or higher than 
3dB and when 2, 3 and 4 kHz frequency amplitudes were 
equal to or higher than 6dB; in both cases wave reprodu-
cibility had to be equal to or higher than 50%. Responses 
from the 2fl-f2 distortion product OAE sites at 70 dB L1 
and L2 signal intensity values, the most robust and well 
perceived, were analyzed.10 DPOAE were considered as 
present when the difference between amplitude and noise 
was over 6dB.
The SPSS 13.0 software was used for multivariate 
data analysis, to observe the effect of independent variables 
(ear assessed and phase of the menstrual cycle) on OAE 
(variable dependent).
RESULTS
Clinical histories and basic audiological testing 
(meatoscopy and pure tone audiometry) were normal in 
our entire sample; there were no impediments for OAE 
testing.
Chart 1 shows mean transient OAE amplitude values 
in right and left ears across the menstrual cycle. A decrease 
in 1 and 4 Hz frequency values may be seen in all three 
menstrual phases.
Chart 1. Mean transient OAE amplitudes in both ears according to the 
phase of the menstrual cycle (luteal, follicular and ovulatory phases).
Chart 2 shows mean transient OAE reproducibility 
values in right and left ears across the menstrual cycle. A 
decrease in 1 and 4 Hz frequency values may be seen in 
all three menstrual phases.
Chart 2. Mean transient OAE reproducibility values in right and left 
ears according to the phase of the menstrual cycle (luteal, follicular 
and ovulatory phases).
Chart 3 shows mean distortion product OAE am-
plitude values in right and left ears across the menstrual 
cycle. A sharp decrease in 1 and 6 Hz frequency values 
may be seen in all three menstrual phases.
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Chart 4 shows the mean product distortion OEA 
signal/noise ratio values in right and left ears across the 
menstrual cycle. A sharp decrease in 1 and 6 Hz frequency 
values may be seen in all three menstrual phases.
Table 1 presents multivariate analysis results sho-
wing the effect of each ear on distortion product OAE 
amplitudes; a single significance value at 1.5 kHz is given, 
the right ear having the highest values.
Tables 2 and 3 present TOEA and DPOEA means 
and standard deviations for each ear that was tested ac-
cording to each menstrual cycle.
DISCUSSION
Transient OAE may be detected in subjects with au-
ditory thresholds up to 30 dB, and distortion product OAE 
may be detected in subjects with auditory thresholds up 
to 45/50 dB.14 DPOAE amplitudes were within the means 
presented in recent papers except at 6 kHz, where values 
were significantly below (over 9 dB) the mean.14,15 TOAE 
amplitudes were slightly above the means published in the 
literature, as seen when comparing the right and left ear 
means in the present study with the general TOAE mean 
in young adults published in 2000.14 
Short-term hormone variations cause changes across 
a woman’s body. These changes may be responsible for 
inner ear conditions such as Ménière’s disease.8 In the 
current study, however, these variations did not result 
in significant changes in OAE responses; this result has 
already been reported in the literature.12 
Differently from Coube and Costa Filho’s15 assess-
ment of distortion product OAE in 100 subjects showing 
no difference between ears, we found a significant diffe-
rence in distortion product OAE at 1.5 kHz between right 
and left ears, where the former had higher values. This 
difference may not be particularly relevant for this test, 
as this frequency is usually little assessed due to noise 
interference from breathing, swallowing, vascular pulse 
and muscle movements.15 Another published paper16 
has shown a noise peak between 1 and 1.5 kHz (mean 
2.3 dB NPS) in distortion product OAE in audiologically 
normal neonates.
There were lower transient OAE amplitudes at 1 and 
4 Hz across the menstrual cycle; lower distortion product 
OAE values were found at 1 and 6 kHz (the first and last 
tested frequencies). This finding may be explained at low 
frequencies, where it may be difficult to separate emissions 
from background noise, probably due to the cochlear to-
notopic distribution.14 On the other hand, higher-voltage 
speakers are needed for identifying responses at high 
frequencies, making these responses harder to detect.17 
Our sample included women aged between 20 and 
35 years, having a regular hormonal cycle and normal he-
aring. It is possible for hormonal cycle phases not to have 
presented significant differences, as both transient and 
distortion product OAE may be detected in normal-hearing 
subjects. The absence of response amplitude changes du-
ring the menstrual cycle may seem surprising, as previous 
Chart 3. Mean distortion product OAE amplitude values in right and 
left ears according to the phase of the menstrual cycle (luteal, follicular 
and ovulatory phases).
Chart 4. Mean product distortion OEA signal/noise ratio values in right 
and left ears according to the phase of the menstrual cycle (luteal, 
follicular and ovulatory phases).
Table 1. Results of the multivariate analysis - effect of each ear on 
distortion product OAE amplitudes.
*Significance - p < 0.05.
Independent variables Dependent variables p
EAR
1000 Hz 0,717
1500 Hz  0,049*
2000 Hz 0,055
2500 Hz 0,526
3000 Hz 0,473
4000 Hz 0,948
5000 Hz 0,741
6000 Hz 0,686
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studies have detected auditory function differences in 
other forms of testing, such as dichotic listening tests5,6 or 
spontaneous OAE testing.13 Changes in auditory responses, 
however, appear to reflect central nervous activity, and 
OAE originate from pre-neural activity.12 Female-specific 
physiological events cause no significant differences in 
OAE responses, meaning that it is unnecessary to take 
the phase of the menstrual cycle into account when in-
terpreting OAE test results.12 Response reliability is stable, 
regardless of the patient’s hormonal cycle phase.
Subjects in our sample did not use anovulatory 
contraceptives during the study; prolonged use of these 
drugs may cause high-frequency sensorineural auditory 
loss.18 Other hormone changes, such as amenorrhea and 
menopause also affect the dynamics of spontaneous OAE 
frequency fluctuations.13 
Our sample was small, which may have contributed 
to the non-significance of the results. Each woman was 
asked to visit the School Clinic three times, once during 
each menstrual cycle phase. Many evaluations were lost, as 
some of the subjects did not return for the last test; it was, 
therefore, hard to conclude the study within the available 
time. The number of participants in similar studies has 
also been small,6,12 underlining the methodological and 
logistical difficulty of this type of investigation.
CONCLUSION
Based on this study we concluded that there were 
no significant differences in transient and distortion pro-
duct OAE according to hormonal cycle phases.
FINAL COMMENTS
We suggest that a similar study be undertaken inclu-
ding a larger sample and different inclusion criteria, such 
as women taking anovulatory contraceptives and women 
of different ages, to assess the effect of the hormonal cycle 
in theses situations.
REFERENCES
 1. Guyton AC. Sexual functions in the female and the female hormones. 
Em: Guyton AC. Text book of medical physiology. Philadelphia: 
Saunders; 1976. p. 1086 - 103.
 2. Molina KL, Brasolotto AG, Berretin-Felix G, Cristovam LS. Modifica-
ção na freqüência fundamental da voz associada à manifestação de 
tensão pré-menstrual. Fonoaudiologia - CFF 2000;(4):12-7.
 3. Bittar RSM, Sanchez TG, Almeida ER, Bensadon RL. Estudo da Fun-
ção Auditiva Durante a Gestação Normal. Arquivos da Fundação 
Otorrinolaringologia, São Paulo, 1997. Disponível em: <http://www.
arquivosdeorl.org.br/conteudo/acervo_port.asp?id=12>
 4. Rode C, Wagner M, Gunturkun O. Menstrual cycle affects functional 
cerebral asymmetries. Neuropsychol 1995;33(7):855-65.
 5. Sanders G, Wenmoth D. Verbal and music dichotic listening tasks 
reveal variations in functional cerebral asymmetry across the 
menstrual cycle that are phase and task dependent. Neuropsychol 
1998;36(9):869-74.
 6. Alexander GM, Altemus M, Peterson BS, Wexler BE. Replication 
of a premenstrual decrease in right-ear advantage on language-
related dichotic listening tests of cerebral laterality. Neuropsychol 
2002;40:1293-9.
 7. Oliveira JAA. Fisiologia clínica da audição: cóclea ativa. Em: Lopes 
Filho O, Campos CAH. Tratado de Otorrinolaringologia. São Paulo: 
Roca; 1994. p.510-30.
 8. Frota S. Fundamentos em fonoaudiologia: audiologia. Rio de Janeiro: 
Guanabara Koogan; 2003.
 9. Pialarissi PR, Gattaz G. Emissões otoacústicas: conceitos básicos e 
aplicações clínicas. Arquivos da Fundação de Otorrinolaringologia, 
São Paulo, 1997.
Table 2. Distribution of TOEA and DPOEA mean values and standard deviations according to each ear that was tested.
TOAE DPOAE
1 1,5 2 3 4 1 1,5 2 2,5 3 4 5 6
dB Mean
OD
OE
12,8
11,1
12,3
16,5
18,3
17,8
16,4
16,4
11,7
12,8
9
8,6
13,5
10,9
13,7
10,7
10,9
10,1
10,1
11
11,7
11,6
12,7
12,3
4,51
5,29
Standard 
deviation 
dB
OD
OE
6,61
6,78
6,52
6,5
5,76
6,63
6,25
7,02
5,52
6,13
6,6
5,6
7,22
7
7,58
8,79
7,1
7,46
7,29
5,89
7,34
6,29
6,67
9,44
10,1
10,4
Table 3. Distribution of TOEA and DPOEA means and standard deviations according to each phase of the menstrual cycle.
TOAE EOAPD
1 1,5 2 3 4 1 1,5 2 2,5 3 4 5 6
Mean 
value dB
Follicular 
ovulatory 
luteous
10,3
13,5
12,1
17,5
16,9
17,7
17,7
18
18,5
16,1
16,4
16,7
12,4
11,5
12,8
9,3
9,1
8,2
12,7
12,2
11,7
12,4
12,6
11,6
10,8
10,3
10,4
10,7
10,5
10,5
11,5
10,9
12,9
12,8
12,4
12,3
11,5
4,25
5,26
Standard 
deviation
dB
Follicular
ovulatory 
luteous
6,67
6,93
6,31
6,45
6,59
6,73
5,52
5,31
6,27
6,77
6,65
6,57
5,79
5,94
5,86
6
5,9
6,5
7,34
7,09
7,34
8,43
7,19
9,34
7,79
7,09
7,09
7,09
6,74
6,12
5,99
5,91
8,28
7,44
8,14
7,32
10,4
10,9
9,65
111
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 74 (1) JANUARY/FEBRUARY 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
10. Carvallo RMM. Fonoaudiologia informação para a formação: proce-
dimentos em audiologia. Rio de Janeiro: Guanabara Koogan; 2003.
11. Russo ICPR, Santos TMM. A prática da audiologia clínica. São Paulo: 
Cortez; 1993.
12. Yellin MW, Stillman RD. Otoacoustic emissions in normal-cycling 
Females. J Am Acad Audiol 1999;10:400-8.
13. Penner MJ. Cycle, amenorrhea, and oral contraception: a brief report. 
Ear Hear 1995;16:428-32.
14. Carvallo RM, Sanches SGG, Ravagnani MP. Amplitude das emissões 
otoacústicas transientes e por produto de distorção em jovens e 
idosos. Rev Bras Otorrinolaringol 2000;66(1):38-45.
15. Coube CZV, Costa Filho OA. Emissões otoacústicas evocadas: produto 
de distorção em indivíduos com audição normal. Rev Bras Otorrino-
laringol 1998;64(4):339-46.
16. Raineri GG, Coube CZV, Costa Filho OA, Alvarenga KF. Emissões 
otoacústicas evocadas - produto de distorção em neonatos audiolo-
gicamente normais. Rev Bras Otorrinolaringol 2001;67(5):644-8.
17. Figueiredo MS. Conhecimentos essenciais para entender bem emis-
sões otoaústicas e bera. São Paulo: Pulso; 2003.
18. Bittar RSM. Labirintopatias hormonais: hormônios esteróides, estró-
geno e progesterona. Arquivos da Fundação de Otorrinolaringologia; 
1997. Disponível em:<http://www.arquivosdeorl.org.br/conteudo/
acervoportasp?id-32>
